These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer. Kitagawa Y; Izumi K; Miwa S; Kadono Y; Konaka H; Mizokami A; Namiki M Anticancer Res; 2013 Oct; 33(10):4497-503. PubMed ID: 24123021 [TBL] [Abstract][Full Text] [Related]
7. Overview of Current and Future Adjuvant Therapy for Muscle-Invasive Urothelial Carcinoma. Nadal R; Apolo AB Curr Treat Options Oncol; 2018 May; 19(7):36. PubMed ID: 29808294 [TBL] [Abstract][Full Text] [Related]
8. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Stenzl A; Cowan NC; De Santis M; Kuczyk MA; Merseburger AS; Ribal MJ; Sherif A; Witjes JA; Eur Urol; 2011 Jun; 59(6):1009-18. PubMed ID: 21454009 [TBL] [Abstract][Full Text] [Related]
9. The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan. Matsui Y; Nishiyama H; Watanabe J; Teramukai S; Ono Y; Ohshima S; Fujimoto K; Hirao Y; Fukushima M; Ogawa O Int J Clin Oncol; 2005 Apr; 10(2):133-8. PubMed ID: 15864700 [TBL] [Abstract][Full Text] [Related]
10. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer. deVere White RW; Katz MH; Steinberg GD J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209 [No Abstract] [Full Text] [Related]
11. Chemotherapy for muscle-invasive bladder cancer in the perioperative setting: current standards. Dreicer R Urol Oncol; 2007; 25(1):72-5. PubMed ID: 17208143 [TBL] [Abstract][Full Text] [Related]
12. Long-term results of two prospective bladder-sparing trimodality approaches for invasive bladder cancer: neoadjuvant chemotherapy and concurrent radio-chemotherapy. Zapatero A; Martin De Vidales C; Arellano R; Ibañez Y; Bocardo G; Perez M; Rabadan M; García Vicente F; Cruz Conde JA; Olivier C Urology; 2012 Nov; 80(5):1056-62. PubMed ID: 22999456 [TBL] [Abstract][Full Text] [Related]
13. Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review. Vashistha V; Quinn DI; Dorff TB; Daneshmand S BMC Cancer; 2014 Dec; 14():966. PubMed ID: 25515347 [TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy in patients with invasive bladder cancer. Vaughn DJ; Malkowicz SB Urol Clin North Am; 2005 May; 32(2):231-7. PubMed ID: 15862620 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of systemic chemotherapy and intra-arterial chemotherapy with/without radiotherapy for bladder preservation or as neo-adjuvant therapy in patients with muscle-invasive bladder cancer: a single-centre study of 163 patients. Miyata Y; Nomata K; Ohba K; Matsuo T; Hayashi N; Sakamoto I; Uetani M; Sakai H Eur J Surg Oncol; 2015 Mar; 41(3):361-7. PubMed ID: 25312685 [TBL] [Abstract][Full Text] [Related]
17. Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer. Izawa JI; Chin JL; Winquist E Can J Urol; 2006 Jun; 13 Suppl 3():48-53. PubMed ID: 16818012 [TBL] [Abstract][Full Text] [Related]
18. Perioperative Systemic Treatment for Muscle-Invasive Bladder Cancer: Current Evidence and Future Perspectives. Kim IH; Lee HJ Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281253 [TBL] [Abstract][Full Text] [Related]